The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1813-1818

  Koene, Harry R ^a   Kleijer, Marion ^a   Swaak, Anton J G ^b   Sullivan, Kathleen E ^c   Bijl, Marc ^d   Petri, Michelle A ^e   Kallenberg, Cees G M ^d   Roos, Dirk ^a   Von Dem Borne, Albert E G K ^a   De Haas, Masja ^a,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE COMPLEX DISEASE; KIDNEY BIOPSY; MACROPHAGE; MALE; NEPHRITIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; CAUCASIAN; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; LUPUS ERYTHEMATOSUS NEPHRITIS;

FC RECEPTOR;

ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 0031595344     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1813::AID-ART13>3.0.CO;2-6     Document Type: Article

References (28)

1. Frank MM, Hamburger MI, Lawly TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979;300:518-23.
2. Davies KA, Peters M, Beynon HLC, Walport MJ. Immune complex processing in patients with systemic lupus erythematosus: in vivo imaging and clearance studies. J Clin Invest 1992;90:2075-83.
3. Anderson CL, Looney RJ, Culp DJ, Ryan DH, Fleit HB, Utell MJ, et al. Alveolar and peritoneal macrophages hear three distinct classes of Fc receptors for IgG. J Immunol 1990;145:196-201.
4. Warmerdam PAM, van de Winkel JGJ, Gosselin EJ, Capel PJA. Molecular basis for a polymorphism of human Fc receptor II (CD32). J Exp Med 1990;172:19-25.
5. Ravetch JV, Perussia B. Alternative membrane forms of FcγRIII (CD16) on human NK cells and neutrophils: cell-type specific expression of two genes which differ in single nucleotide substitutions. J Exp Med 1989;170:481-97.
6. De Haas M, Koene HR, Kleijer M, De Vries E, Simsek S, van Tol MJD, et al. A triallelic Fc receptor type IIIA polymorphism influences the binding of human IgG by NK cell FcγRIIIA. J Immunol 1996;156:2948-55.
7. Parren PWHI, Warmerdam PAM, Boeije LCM, Arts J, Westerwaal NAC, Vlug A, et al. On the interaction of IgG subclasses with the low-affinity FcγRIIA (CD32) on human monocytes, neutrophils and platelets. J Clin Invest 1992;90:1537-41.
8. Koene HR, Kleijer M, Algra J, Roos D, von dem Borne AEGK, de Haas M. FcγRIIIA-158V/F polymorphism influences the binding of IgG by NK cell FcγRIIIA, independently of the FcγRIIIA-48L/ R/H phenotype. Blood 1997;90:1109-14.
9. Wilson ME, Kalmar JR. FcγRIIA (CD32): a potential marker defining susceptibility to localized juvenile periodontitis. J Periodontol 1996;67:323-31.
10. Sanders LAM, van de Winkel JGJ, Rijkers GT, Voorhorst-Ogink MM, de Haas M, Capel PJA, et al. Fcgamma receptor IIA (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 1994;170:854-61.
11. Bredius RGM, Derkx BHF, Fijen CAP, De Wit TPM, de Haas M, Weening RS, et al. Fcgamma receptor IIA (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170:848-53.
12. Fijen CAP, Bredius RGM, Kuijper EJ. Polymorphisms of IgG Fc receptors in meningococcal disease [letter]. Ann Intern Med 1993;119:636.
13. Harley JB, Sheldon P, Neas B, Murphy S, Wallace DJ, Scofield RH, et al. Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol 1994;103:144S-9S.
14. Blasini AM, Stekman IL, Leon-Ponte M, Caldera D, Rodriguez MA. Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1993;94:423-8.
15. Duits AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Fc receptor IIA (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1996;39: 1832-6.
16. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
17. Botto M, Theodoridis E, Thompson EM, Beynon HLC, Briggs D, Isenberg DA, et al. FcgRIIA polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol 1996;104:264-8.
18. Song YW, Han C-W, Kang S-W, Baek H-J, Lee E-B, Shin C-H, et al. Abnormal distribution of Fcγ receptor type IIA polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:421-6.
19. Hasely LA, Wisnieski JJ, Denburg MR, Michael-Grossman AR, Ginzler EM, Gourley MF, et al. Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles. Kidney Int 1997;52:1375-80.
20. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. De Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AEGK Neutrophil FcgammaRIIIB deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403-13.
22. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, et al. A novel polymorphism of FcγRIIIA (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059-70.
23. Radeke HH, Gessner JE, Uciechowski P, Magert HJ, Schmidt RE, Resch K. Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (HFcγRIII-A) and the associated FcRI gamma-chain. J Immunol 1994;153:1281-92.
24. Klippel JH. Systemic lupus erythematosus: demographics, prognosis and outcome. J Rheumatol 1997;24 Suppl 48:67-71.
25. Tsao BP, Cantor RM, Kalunian KC, Chen C, Badsha H, Singh R, et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 1997;99:725-31.
26. Luan JJ, Monteiro RC, Sautes C, Fluteau G, Eloy L, Fridman WH, et al. Defective FcγRII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum. J Immunol 1996;157:4707-16.
27. Vyse TJ, Rozzo SJ, Drake CG, Izui S, Kotzin BL. Control of multiple autoantibodies linked with a lupus nephritis susceptibility in New Zealand Black mice. J Immunol 1997;158:5566-74.
28. Lahita RG. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone; 1992.